SCHEMBL25680845

SCHEMBL25680845

CCOC(=O)Cc1ncc(C)cn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
HSD17B10 Q99714 2/20 0.50
PKM P14618 1/20 0.50
ATM Q13315 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
KDM4E B2RXH2 4/20 0.45
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
DPP4 P27487 2/20 0.40
ALDH1A1 P00352 5/20 0.40
TSHR P16473 1/20 0.40
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4219818 0.87 SMN1; SMN2 (0.49) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL21880026 0.85 SMN1; SMN2 (0.55) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL30720842 0.85 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL31505752 0.85 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL15415823 0.85 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL12457570 0.82 HSP90AB1 (0.41) HSD17B10ATMKDM4EGAAALDH1A1
SCHEMBL7890254 0.82 CA12 (0.51) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL25096492 0.82 SMN1; SMN2 (0.45) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL21880024 0.82 SMN1; SMN2 (0.45) SMN1; SMN2HSD17B10PKMATMCA12
SCHEMBL29104397 0.81 CA12 (0.50) SMN1; SMN2HSD17B10PKMATMCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137329-A1 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2024-06-27 WO disclosed
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed